Frequently Asked Questions Frequently Asked Questions Can you switch directly from Ozempic to Zepbound
For patients without insurance or with limited coverage, the cost may be higher
Any class-level safety concerns could slow retatrutide's review regardless of its individual trial data
However, Rybelsus is only approved for managing Type 2 diabetes and cardiovascular risk, and is not indicated for weight loss
Cardiovascular Health Risk Reduction : Through weight reduction and improved metabolic parameters, cagrilintide may help reduce cardiovascular risks commonly associated with obesity and type 2 diabetes ( 1, 3 )
Data Availability Lilly provides access to all individual participant data collected during the trial, after anonymization, with the exception of PK or genetic data